Back
Eiffage SA Vs. Janux Therapeutics Industry Stock Comparison
Sell
39
EFGSY
Eiffage SA
Last Price:
17.92
Seasonality Move:
5.16%
Sell
34
JANX
Janux Therapeutics
Last Price:
69.51
Seasonality Move:
133.13%
Sell
39
Eiffage SA (EFGSY)
is a Sell
Is Eiffage SA a Buy, Sell or Hold?
- The current Eiffage SA [EFGSY] share price is $17.35. The Score for EFGSY is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- EFGSY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EFGSY Stock Price Chart
What is Eiffage SA's stock price today?
-
The Eiffage SA share price today is $17.35
The current trend is relatively stagnant and EFGSY is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $59.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
EFGSY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 41.82 | Sell |
Chaikin Money Flow: | -3428 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.5 - 18.38) | Sell |
Bollinger Bands (100): | (18.31 - 20.61) | Sell |
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 63.62 | Buy |
Chaikin Money Flow: | -6955717 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.07 - 55.53) | Buy |
Bollinger Bands (100): | (41.63 - 51.75) | Buy |
EFGSY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 17.65 | Sell |
20-day SMA: | 17.78 | Sell |
50-day SMA: | 18.58 | Sell |
200-day SMA: | 20.38 | Sell |
8-day EMA: | 17.61 | Sell |
20-day EMA: | 17.86 | Sell |
50-day EMA: | 18.51 | Sell |
200-day EMA: | 19.8 | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.16 | Buy |
20-day SMA: | 50.4 | Buy |
50-day SMA: | 49.88 | Buy |
200-day SMA: | 44.87 | Buy |
8-day EMA: | 49.16 | Buy |
20-day EMA: | 49.72 | Buy |
50-day EMA: | 49.41 | Buy |
200-day EMA: | 41.75 | Buy |
Eiffage SA Earnings Growth & EFGSY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.
Eiffage SA Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Janux Therapeutics Technical Analysis
Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |